Drug Discovery Quotes

The problem of chemotherapy of bacterial infections could be solved neither by the experimental medical research worker nor by the chemist alone, but only by the two together working in very close cooperation over many years.

There is no doubt that the Mindset failure is a major setback for Axovant, but it is not the end of the road.

The discovery of artemisinin was an example of successful collective efforts.

I did help to set up an undergraduate course in medicinal chemistry and made progress in modelling and analysing pharmacological activity at the tissue level, my new passion.

And there are lots of drug companies that are working on cure or medicine.

Fortunately, in Piramal Enterprises, we are in three broad sectors. One is in the whole financial services sector, the second is in pharmaceuticals, and the third is in healthcare analytics and data.

Aspen's investment in TesoRx will assist in the work being undertaken to bring this product to market and in investing behind TesoRx's pipeline and technology that has the potential to be used for a wide range of different applications.

I fell in love with the science at Merck.

Financial risk is always associated with drug discovery. But the benefit that a blockbuster drug can bring to the business can be phenomenal if you can take that risk.

In research, I wanted to establish the medicinal chemistry/bioassay conjugation as an academic pursuit, as exciting to the imagination as astrophysics or molecular biology.

Data-intensive graph problems abound in the Life Science drug discovery and development process.

I keep encouraging the pharmaceutical companies to put more money into R&D.

As analytical pharmacologists, what we are allowed to see of a new molecule's properties is totally dependent on the techniques of bioassay we use.

I want to make a drug. I want the science to be more than imaginary, where I think, 'We're learning these fundamental principles, blah, blah, blah, blah, blah.' I think we are doing that, but I want to do something really practical. I want to actually, in my lifetime, help people.

There is probably a promising drug candidate that has already been discovered for the treatment of Down syndrome that is sitting on the shelf of some drug company.

Getting a traditional pharmaceutical to the market can cost a billion dollars or more. Newer, more tailored and targeted drugs called biologics are even more complex and expensive. Simple economics dictates that companies and venture funds will invest more in products that can generate a sufficient return.

I was criticized for saying that Pfizer doesn't know how to make a molecule right.

I'd like to focus on my life on creating new medicines for people who are suffering from rare disease.

Roivant does not view - and has never viewed - Axovant as simply a 'vehicle' for developing intepirdine, but instead as a platform for the development of high-impact drugs in dementia and the neuroscience field more generally.

We are trying to find drugs, small molecules, that people could take to make them disease-resistant, more youthful and healthy. Eventually we will find them.

The discovery of streptomycin as a product of a rather obscure group of microorganisms, the actinomycetes, led to the study of these organisms as potential producers of other chemotherapeutic substances.

AI will be critical in the race for innovation power, lying behind countless future developments in drug discovery, gene therapy, material science, and clean energy—and in AI itself. Faster airplanes did not help build faster airplanes, but faster computers will help build faster computers. 

To develop drugs for people, we basically dismantle the system. In the lab, we look at things the size of a cell or two. We dismantle life into very small models.

We should revel in tons and tons and tons of ideas. Some of them will manifest and lead to a drug discovery, and some will not.

If we can actually decrease the failure rate from nine out of 10 drugs failing in clinical trials and instead have seven out of 10 instead failing, that is a major victory for drug discovery and for people having better therapy.